Corporate calendar for BioNTech SE (BNTX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
BioNTech SE, a biotechnology firm, specializes in the creation and marketing of immune-based treatments for malignancies and various infectious diseases. A significant part of its oncology pipeline includes the FixVac cancer vaccine program, which features several candidates in different phases of clinical development: BNT111 is in Phase 2 for advanced melanoma. BNT112 has reached Phase 1/2a for prostate cancer.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-16 | ||
| 2026-09-16 | $47M | |
| 2026-09-16 | $565M | |
| 2026-09-16 | ||
| 2026-09-16 | $-0.72 | |
| 2026-09-16 | $17M |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2022-06-02 | $2.1110 | 8.79% |
Price
| Price | $96.06 |
| Market Cap | $24.1B |
| Exchange | NASDAQ |
| Country | DE |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 20 |
| Hold | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 24 |
| Avg rating (1-5) | 0.83 |
Related companies: BIIB · DXCM · GMAB · INCY · NTRA · PHG · RPRX
Explore sector: Healthcare · Biotechnology
More sections of BNTX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks